DELRAY BEACH, Fla., Aug. 9, 2010 (GLOBE NEWSWIRE) -- PositiveID Corporation (“PositiveID” or the “Company”) (Nasdaq:PSID) announced today that it has filed a provisional patent application with the U.S. Patent and Trademark Office for an insulin pen tracking and recording device. The Insulin Tracker, a microprocessor-controlled device that slides onto standard insulin pens, enables diabetes patients to automatically track and record the amount of insulin they inject, including the time and date of each injection. The data is communicated from the Insulin Tracker’s memory, along with the patient’s blood glucose readings from their glucometer, to the iGlucose System database. The combined data provides a more complete record of blood glucose measurements, treatments and overall diabetes management and allows patients, caregivers and physicians to monitor compliance.
